The Non-Invasive Prenatal Testing (NIPT) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Non-Invasive Prenatal Testing (NIPT) size is estimated to be USD 4788.6 million in 2026 from USD 3331.3 million in 2020, with a change XX% between 2020 and 2021. The global Non-Invasive Prenatal Testing (NIPT) market size is expected to grow at a CAGR of 9.5% for the next five years.
Market segmentation
Non-Invasive Prenatal Testing (NIPT) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Ultrasound
NGS
PCR
Microarray
Market segment by Application, can be divided into
Hospital
Diagnostic Labs
Market segment by players, this report covers
GE Healthcare
Koninklijke Philips
Illumina
Thermo Fisher Scientific
F. Hoffman-La Roche
Pacific Biosciences Of California
Perkinelmer
Qiagen
Agilent Technologies
Beijing Genomics Institute
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Non-Invasive Prenatal Testing (NIPT) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Non-Invasive Prenatal Testing (NIPT), with revenue, gross margin and global market share of Non-Invasive Prenatal Testing (NIPT) from 2019 to 2021.
Chapter 3, the Non-Invasive Prenatal Testing (NIPT) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Non-Invasive Prenatal Testing (NIPT) market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Non-Invasive Prenatal Testing (NIPT) research findings and conclusion, appendix and data source.
According to our latest research, the global Non-Invasive Prenatal Testing (NIPT) size is estimated to be USD 4788.6 million in 2026 from USD 3331.3 million in 2020, with a change XX% between 2020 and 2021. The global Non-Invasive Prenatal Testing (NIPT) market size is expected to grow at a CAGR of 9.5% for the next five years.
Market segmentation
Non-Invasive Prenatal Testing (NIPT) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Ultrasound
NGS
PCR
Microarray
Market segment by Application, can be divided into
Hospital
Diagnostic Labs
Market segment by players, this report covers
GE Healthcare
Koninklijke Philips
Illumina
Thermo Fisher Scientific
F. Hoffman-La Roche
Pacific Biosciences Of California
Perkinelmer
Qiagen
Agilent Technologies
Beijing Genomics Institute
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Non-Invasive Prenatal Testing (NIPT) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Non-Invasive Prenatal Testing (NIPT), with revenue, gross margin and global market share of Non-Invasive Prenatal Testing (NIPT) from 2019 to 2021.
Chapter 3, the Non-Invasive Prenatal Testing (NIPT) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Non-Invasive Prenatal Testing (NIPT) market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Non-Invasive Prenatal Testing (NIPT) research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Non-Invasive Prenatal Testing (NIPT)
1.2 Classification of Non-Invasive Prenatal Testing (NIPT) by Type
1.2.1 Overview: Global Non-Invasive Prenatal Testing (NIPT) Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Non-Invasive Prenatal Testing (NIPT) Revenue Market Share by Type in 2020
1.2.3 Ultrasound
1.2.4 NGS
1.2.5 PCR
1.2.6 Microarray
1.3 Global Non-Invasive Prenatal Testing (NIPT) Market by Application
1.3.1 Overview: Global Non-Invasive Prenatal Testing (NIPT) Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Diagnostic Labs
1.4 Global Non-Invasive Prenatal Testing (NIPT) Market Size & Forecast
1.5 Global Non-Invasive Prenatal Testing (NIPT) Market Size and Forecast by Region
1.5.1 Global Non-Invasive Prenatal Testing (NIPT) Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Non-Invasive Prenatal Testing (NIPT) Market Size by Region, (2016-2021)
1.5.3 North America Non-Invasive Prenatal Testing (NIPT) Market Size and Prospect (2016-2026)
1.5.4 Europe Non-Invasive Prenatal Testing (NIPT) Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Non-Invasive Prenatal Testing (NIPT) Market Size and Prospect (2016-2026)
1.5.6 South America Non-Invasive Prenatal Testing (NIPT) Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Non-Invasive Prenatal Testing (NIPT) Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Non-Invasive Prenatal Testing (NIPT) Market Drivers
1.6.2 Non-Invasive Prenatal Testing (NIPT) Market Restraints
1.6.3 Non-Invasive Prenatal Testing (NIPT) Trends Analysis
2 Company Profiles
2.1 GE Healthcare
2.1.1 GE Healthcare Details
2.1.2 GE Healthcare Major Business
2.1.3 GE Healthcare Non-Invasive Prenatal Testing (NIPT) Product and Solutions
2.1.4 GE Healthcare Non-Invasive Prenatal Testing (NIPT) Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 GE Healthcare Recent Developments and Future Plans
2.2 Koninklijke Philips
2.2.1 Koninklijke Philips Details
2.2.2 Koninklijke Philips Major Business
2.2.3 Koninklijke Philips Non-Invasive Prenatal Testing (NIPT) Product and Solutions
2.2.4 Koninklijke Philips Non-Invasive Prenatal Testing (NIPT) Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Koninklijke Philips Recent Developments and Future Plans
2.3 Illumina
2.3.1 Illumina Details
2.3.2 Illumina Major Business
2.3.3 Illumina Non-Invasive Prenatal Testing (NIPT) Product and Solutions
2.3.4 Illumina Non-Invasive Prenatal Testing (NIPT) Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Illumina Recent Developments and Future Plans
2.4 Thermo Fisher Scientific
2.4.1 Thermo Fisher Scientific Details
2.4.2 Thermo Fisher Scientific Major Business
2.4.3 Thermo Fisher Scientific Non-Invasive Prenatal Testing (NIPT) Product and Solutions
2.4.4 Thermo Fisher Scientific Non-Invasive Prenatal Testing (NIPT) Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.5 F. Hoffman-La Roche
2.5.1 F. Hoffman-La Roche Details
2.5.2 F. Hoffman-La Roche Major Business
2.5.3 F. Hoffman-La Roche Non-Invasive Prenatal Testing (NIPT) Product and Solutions
2.5.4 F. Hoffman-La Roche Non-Invasive Prenatal Testing (NIPT) Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 F. Hoffman-La Roche Recent Developments and Future Plans
2.6 Pacific Biosciences Of California
2.6.1 Pacific Biosciences Of California Details
2.6.2 Pacific Biosciences Of California Major Business
2.6.3 Pacific Biosciences Of California Non-Invasive Prenatal Testing (NIPT) Product and Solutions
2.6.4 Pacific Biosciences Of California Non-Invasive Prenatal Testing (NIPT) Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Pacific Biosciences Of California Recent Developments and Future Plans
2.7 Perkinelmer
2.7.1 Perkinelmer Details
2.7.2 Perkinelmer Major Business
2.7.3 Perkinelmer Non-Invasive Prenatal Testing (NIPT) Product and Solutions
2.7.4 Perkinelmer Non-Invasive Prenatal Testing (NIPT) Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Perkinelmer Recent Developments and Future Plans
2.8 Qiagen
2.8.1 Qiagen Details
2.8.2 Qiagen Major Business
2.8.3 Qiagen Non-Invasive Prenatal Testing (NIPT) Product and Solutions
2.8.4 Qiagen Non-Invasive Prenatal Testing (NIPT) Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Qiagen Recent Developments and Future Plans
2.9 Agilent Technologies
2.9.1 Agilent Technologies Details
2.9.2 Agilent Technologies Major Business
2.9.3 Agilent Technologies Non-Invasive Prenatal Testing (NIPT) Product and Solutions
2.9.4 Agilent Technologies Non-Invasive Prenatal Testing (NIPT) Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Agilent Technologies Recent Developments and Future Plans
2.10 Beijing Genomics Institute
2.10.1 Beijing Genomics Institute Details
2.10.2 Beijing Genomics Institute Major Business
2.10.3 Beijing Genomics Institute Non-Invasive Prenatal Testing (NIPT) Product and Solutions
2.10.4 Beijing Genomics Institute Non-Invasive Prenatal Testing (NIPT) Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Beijing Genomics Institute Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Non-Invasive Prenatal Testing (NIPT) Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Non-Invasive Prenatal Testing (NIPT) Players Market Share
3.2.2 Top 10 Non-Invasive Prenatal Testing (NIPT) Players Market Share
3.2.3 Market Competition Trend
3.3 Non-Invasive Prenatal Testing (NIPT) Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Non-Invasive Prenatal Testing (NIPT) Revenue and Market Share by Type (2016-2021)
4.2 Global Non-Invasive Prenatal Testing (NIPT) Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Non-Invasive Prenatal Testing (NIPT) Revenue Market Share by Application (2016-2021)
5.2 Non-Invasive Prenatal Testing (NIPT) Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Non-Invasive Prenatal Testing (NIPT) Revenue by Type (2016-2026)
6.2 North America Non-Invasive Prenatal Testing (NIPT) Revenue by Application (2016-2026)
6.3 North America Non-Invasive Prenatal Testing (NIPT) Market Size by Country
6.3.1 North America Non-Invasive Prenatal Testing (NIPT) Revenue by Country (2016-2026)
6.3.2 United States Non-Invasive Prenatal Testing (NIPT) Market Size and Forecast (2016-2026)
6.3.3 Canada Non-Invasive Prenatal Testing (NIPT) Market Size and Forecast (2016-2026)
6.3.4 Mexico Non-Invasive Prenatal Testing (NIPT) Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Non-Invasive Prenatal Testing (NIPT) Revenue by Type (2016-2026)
7.2 Europe Non-Invasive Prenatal Testing (NIPT) Revenue by Application (2016-2026)
7.3 Europe Non-Invasive Prenatal Testing (NIPT) Market Size by Country
7.3.1 Europe Non-Invasive Prenatal Testing (NIPT) Revenue by Country (2016-2026)
7.3.2 Germany Non-Invasive Prenatal Testing (NIPT) Market Size and Forecast (2016-2026)
7.3.3 France Non-Invasive Prenatal Testing (NIPT) Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Non-Invasive Prenatal Testing (NIPT) Market Size and Forecast (2016-2026)
7.3.5 Russia Non-Invasive Prenatal Testing (NIPT) Market Size and Forecast (2016-2026)
7.3.6 Italy Non-Invasive Prenatal Testing (NIPT) Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Non-Invasive Prenatal Testing (NIPT) Revenue by Type (2016-2026)
8.2 Asia-Pacific Non-Invasive Prenatal Testing (NIPT) Revenue by Application (2016-2026)
8.3 Asia-Pacific Non-Invasive Prenatal Testing (NIPT) Market Size by Region
8.3.1 Asia-Pacific Non-Invasive Prenatal Testing (NIPT) Revenue by Region (2016-2026)
8.3.2 China Non-Invasive Prenatal Testing (NIPT) Market Size and Forecast (2016-2026)
8.3.3 Japan Non-Invasive Prenatal Testing (NIPT) Market Size and Forecast (2016-2026)
8.3.4 South Korea Non-Invasive Prenatal Testing (NIPT) Market Size and Forecast (2016-2026)
8.3.5 India Non-Invasive Prenatal Testing (NIPT) Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Non-Invasive Prenatal Testing (NIPT) Market Size and Forecast (2016-2026)
8.3.7 Australia Non-Invasive Prenatal Testing (NIPT) Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Non-Invasive Prenatal Testing (NIPT) Revenue by Type (2016-2026)
9.2 South America Non-Invasive Prenatal Testing (NIPT) Revenue by Application (2016-2026)
9.3 South America Non-Invasive Prenatal Testing (NIPT) Market Size by Country
9.3.1 South America Non-Invasive Prenatal Testing (NIPT) Revenue by Country (2016-2026)
9.3.2 Brazil Non-Invasive Prenatal Testing (NIPT) Market Size and Forecast (2016-2026)
9.3.3 Argentina Non-Invasive Prenatal Testing (NIPT) Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Non-Invasive Prenatal Testing (NIPT) Revenue by Type (2016-2026)
10.2 Middle East & Africa Non-Invasive Prenatal Testing (NIPT) Revenue by Application (2016-2026)
10.3 Middle East & Africa Non-Invasive Prenatal Testing (NIPT) Market Size by Country
10.3.1 Middle East & Africa Non-Invasive Prenatal Testing (NIPT) Revenue by Country (2016-2026)
10.3.2 Turkey Non-Invasive Prenatal Testing (NIPT) Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Non-Invasive Prenatal Testing (NIPT) Market Size and Forecast (2016-2026)
10.3.4 UAE Non-Invasive Prenatal Testing (NIPT) Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Product Overview and Scope of Non-Invasive Prenatal Testing (NIPT)
1.2 Classification of Non-Invasive Prenatal Testing (NIPT) by Type
1.2.1 Overview: Global Non-Invasive Prenatal Testing (NIPT) Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Non-Invasive Prenatal Testing (NIPT) Revenue Market Share by Type in 2020
1.2.3 Ultrasound
1.2.4 NGS
1.2.5 PCR
1.2.6 Microarray
1.3 Global Non-Invasive Prenatal Testing (NIPT) Market by Application
1.3.1 Overview: Global Non-Invasive Prenatal Testing (NIPT) Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Diagnostic Labs
1.4 Global Non-Invasive Prenatal Testing (NIPT) Market Size & Forecast
1.5 Global Non-Invasive Prenatal Testing (NIPT) Market Size and Forecast by Region
1.5.1 Global Non-Invasive Prenatal Testing (NIPT) Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Non-Invasive Prenatal Testing (NIPT) Market Size by Region, (2016-2021)
1.5.3 North America Non-Invasive Prenatal Testing (NIPT) Market Size and Prospect (2016-2026)
1.5.4 Europe Non-Invasive Prenatal Testing (NIPT) Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Non-Invasive Prenatal Testing (NIPT) Market Size and Prospect (2016-2026)
1.5.6 South America Non-Invasive Prenatal Testing (NIPT) Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Non-Invasive Prenatal Testing (NIPT) Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Non-Invasive Prenatal Testing (NIPT) Market Drivers
1.6.2 Non-Invasive Prenatal Testing (NIPT) Market Restraints
1.6.3 Non-Invasive Prenatal Testing (NIPT) Trends Analysis
2 Company Profiles
2.1 GE Healthcare
2.1.1 GE Healthcare Details
2.1.2 GE Healthcare Major Business
2.1.3 GE Healthcare Non-Invasive Prenatal Testing (NIPT) Product and Solutions
2.1.4 GE Healthcare Non-Invasive Prenatal Testing (NIPT) Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 GE Healthcare Recent Developments and Future Plans
2.2 Koninklijke Philips
2.2.1 Koninklijke Philips Details
2.2.2 Koninklijke Philips Major Business
2.2.3 Koninklijke Philips Non-Invasive Prenatal Testing (NIPT) Product and Solutions
2.2.4 Koninklijke Philips Non-Invasive Prenatal Testing (NIPT) Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Koninklijke Philips Recent Developments and Future Plans
2.3 Illumina
2.3.1 Illumina Details
2.3.2 Illumina Major Business
2.3.3 Illumina Non-Invasive Prenatal Testing (NIPT) Product and Solutions
2.3.4 Illumina Non-Invasive Prenatal Testing (NIPT) Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Illumina Recent Developments and Future Plans
2.4 Thermo Fisher Scientific
2.4.1 Thermo Fisher Scientific Details
2.4.2 Thermo Fisher Scientific Major Business
2.4.3 Thermo Fisher Scientific Non-Invasive Prenatal Testing (NIPT) Product and Solutions
2.4.4 Thermo Fisher Scientific Non-Invasive Prenatal Testing (NIPT) Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.5 F. Hoffman-La Roche
2.5.1 F. Hoffman-La Roche Details
2.5.2 F. Hoffman-La Roche Major Business
2.5.3 F. Hoffman-La Roche Non-Invasive Prenatal Testing (NIPT) Product and Solutions
2.5.4 F. Hoffman-La Roche Non-Invasive Prenatal Testing (NIPT) Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 F. Hoffman-La Roche Recent Developments and Future Plans
2.6 Pacific Biosciences Of California
2.6.1 Pacific Biosciences Of California Details
2.6.2 Pacific Biosciences Of California Major Business
2.6.3 Pacific Biosciences Of California Non-Invasive Prenatal Testing (NIPT) Product and Solutions
2.6.4 Pacific Biosciences Of California Non-Invasive Prenatal Testing (NIPT) Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Pacific Biosciences Of California Recent Developments and Future Plans
2.7 Perkinelmer
2.7.1 Perkinelmer Details
2.7.2 Perkinelmer Major Business
2.7.3 Perkinelmer Non-Invasive Prenatal Testing (NIPT) Product and Solutions
2.7.4 Perkinelmer Non-Invasive Prenatal Testing (NIPT) Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Perkinelmer Recent Developments and Future Plans
2.8 Qiagen
2.8.1 Qiagen Details
2.8.2 Qiagen Major Business
2.8.3 Qiagen Non-Invasive Prenatal Testing (NIPT) Product and Solutions
2.8.4 Qiagen Non-Invasive Prenatal Testing (NIPT) Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Qiagen Recent Developments and Future Plans
2.9 Agilent Technologies
2.9.1 Agilent Technologies Details
2.9.2 Agilent Technologies Major Business
2.9.3 Agilent Technologies Non-Invasive Prenatal Testing (NIPT) Product and Solutions
2.9.4 Agilent Technologies Non-Invasive Prenatal Testing (NIPT) Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Agilent Technologies Recent Developments and Future Plans
2.10 Beijing Genomics Institute
2.10.1 Beijing Genomics Institute Details
2.10.2 Beijing Genomics Institute Major Business
2.10.3 Beijing Genomics Institute Non-Invasive Prenatal Testing (NIPT) Product and Solutions
2.10.4 Beijing Genomics Institute Non-Invasive Prenatal Testing (NIPT) Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Beijing Genomics Institute Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Non-Invasive Prenatal Testing (NIPT) Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Non-Invasive Prenatal Testing (NIPT) Players Market Share
3.2.2 Top 10 Non-Invasive Prenatal Testing (NIPT) Players Market Share
3.2.3 Market Competition Trend
3.3 Non-Invasive Prenatal Testing (NIPT) Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Non-Invasive Prenatal Testing (NIPT) Revenue and Market Share by Type (2016-2021)
4.2 Global Non-Invasive Prenatal Testing (NIPT) Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Non-Invasive Prenatal Testing (NIPT) Revenue Market Share by Application (2016-2021)
5.2 Non-Invasive Prenatal Testing (NIPT) Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Non-Invasive Prenatal Testing (NIPT) Revenue by Type (2016-2026)
6.2 North America Non-Invasive Prenatal Testing (NIPT) Revenue by Application (2016-2026)
6.3 North America Non-Invasive Prenatal Testing (NIPT) Market Size by Country
6.3.1 North America Non-Invasive Prenatal Testing (NIPT) Revenue by Country (2016-2026)
6.3.2 United States Non-Invasive Prenatal Testing (NIPT) Market Size and Forecast (2016-2026)
6.3.3 Canada Non-Invasive Prenatal Testing (NIPT) Market Size and Forecast (2016-2026)
6.3.4 Mexico Non-Invasive Prenatal Testing (NIPT) Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Non-Invasive Prenatal Testing (NIPT) Revenue by Type (2016-2026)
7.2 Europe Non-Invasive Prenatal Testing (NIPT) Revenue by Application (2016-2026)
7.3 Europe Non-Invasive Prenatal Testing (NIPT) Market Size by Country
7.3.1 Europe Non-Invasive Prenatal Testing (NIPT) Revenue by Country (2016-2026)
7.3.2 Germany Non-Invasive Prenatal Testing (NIPT) Market Size and Forecast (2016-2026)
7.3.3 France Non-Invasive Prenatal Testing (NIPT) Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Non-Invasive Prenatal Testing (NIPT) Market Size and Forecast (2016-2026)
7.3.5 Russia Non-Invasive Prenatal Testing (NIPT) Market Size and Forecast (2016-2026)
7.3.6 Italy Non-Invasive Prenatal Testing (NIPT) Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Non-Invasive Prenatal Testing (NIPT) Revenue by Type (2016-2026)
8.2 Asia-Pacific Non-Invasive Prenatal Testing (NIPT) Revenue by Application (2016-2026)
8.3 Asia-Pacific Non-Invasive Prenatal Testing (NIPT) Market Size by Region
8.3.1 Asia-Pacific Non-Invasive Prenatal Testing (NIPT) Revenue by Region (2016-2026)
8.3.2 China Non-Invasive Prenatal Testing (NIPT) Market Size and Forecast (2016-2026)
8.3.3 Japan Non-Invasive Prenatal Testing (NIPT) Market Size and Forecast (2016-2026)
8.3.4 South Korea Non-Invasive Prenatal Testing (NIPT) Market Size and Forecast (2016-2026)
8.3.5 India Non-Invasive Prenatal Testing (NIPT) Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Non-Invasive Prenatal Testing (NIPT) Market Size and Forecast (2016-2026)
8.3.7 Australia Non-Invasive Prenatal Testing (NIPT) Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Non-Invasive Prenatal Testing (NIPT) Revenue by Type (2016-2026)
9.2 South America Non-Invasive Prenatal Testing (NIPT) Revenue by Application (2016-2026)
9.3 South America Non-Invasive Prenatal Testing (NIPT) Market Size by Country
9.3.1 South America Non-Invasive Prenatal Testing (NIPT) Revenue by Country (2016-2026)
9.3.2 Brazil Non-Invasive Prenatal Testing (NIPT) Market Size and Forecast (2016-2026)
9.3.3 Argentina Non-Invasive Prenatal Testing (NIPT) Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Non-Invasive Prenatal Testing (NIPT) Revenue by Type (2016-2026)
10.2 Middle East & Africa Non-Invasive Prenatal Testing (NIPT) Revenue by Application (2016-2026)
10.3 Middle East & Africa Non-Invasive Prenatal Testing (NIPT) Market Size by Country
10.3.1 Middle East & Africa Non-Invasive Prenatal Testing (NIPT) Revenue by Country (2016-2026)
10.3.2 Turkey Non-Invasive Prenatal Testing (NIPT) Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Non-Invasive Prenatal Testing (NIPT) Market Size and Forecast (2016-2026)
10.3.4 UAE Non-Invasive Prenatal Testing (NIPT) Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
